Spring Day Competitors

SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for.

At Bold Spring Nursery we don’t just grow trees, we Build Trees. With a goal of bringing long term value to our customers and communities, we actively pursue building a more valuable tree. When shipped, our fully developed trees are ready to reach their full natural potential in longevity, appearance (both at delivery and long term), and their ability to deliver maximum environmental and economic benefits over the course of their lives.

We are a Seattle-based strategy consultancy focusing on advocacy and communications in the non-profit space with experience in global health and development, homeless youth, and K-12 education. Our consultants have a minimum of 10 years of experience and a blend of for- and non-profit experience.